These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
27-1204330
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
1 Primerica Parkway
Duluth, Georgia
|
30099
|
|
(Address of principal executive offices)
|
(ZIP Code)
|
|
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
Class
|
|
As of April 30, 2013
|
|
Common Stock, $.01 Par Value
|
|
56,987,377 shares
|
|
|
Page
|
|
|
|
|
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(unaudited)
|
|
|||||
|
|
(In thousands)
|
||||||
|
Assets
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Fixed-maturity securities available for sale, at fair value (amortized cost: $1,671,700 in 2013 and $1,711,582 in 2012)
|
$
|
1,837,929
|
|
|
$
|
1,887,014
|
|
|
Equity securities available for sale, at fair value (cost: $31,066 in 2013 and $29,955 in 2012)
|
40,277
|
|
|
37,147
|
|
||
|
Trading securities, at fair value (cost: $9,394 in 2013 and $7,740 in 2012)
|
9,417
|
|
|
7,762
|
|
||
|
Policy loans
|
25,009
|
|
|
24,613
|
|
||
|
Total investments
|
1,912,632
|
|
|
1,956,536
|
|
||
|
Cash and cash equivalents
|
202,512
|
|
|
112,216
|
|
||
|
Accrued investment income
|
21,391
|
|
|
19,540
|
|
||
|
Due from reinsurers
|
4,005,539
|
|
|
4,005,194
|
|
||
|
Deferred policy acquisition costs, net
|
1,098,124
|
|
|
1,066,422
|
|
||
|
Premiums and other receivables
|
180,347
|
|
|
170,656
|
|
||
|
Intangible assets, net (accumulated amortization: $62,472 in 2013 and $61,621 in 2012)
|
69,502
|
|
|
69,816
|
|
||
|
Income taxes
|
21,359
|
|
|
17,256
|
|
||
|
Other assets
|
307,241
|
|
|
302,126
|
|
||
|
Separate account assets
|
2,614,669
|
|
|
2,618,115
|
|
||
|
Total assets
|
$
|
10,433,316
|
|
|
$
|
10,337,877
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Future policy benefits
|
$
|
4,898,538
|
|
|
$
|
4,850,488
|
|
|
Unearned premiums
|
10,214
|
|
|
6,056
|
|
||
|
Policy claims and other benefits payable
|
254,333
|
|
|
254,533
|
|
||
|
Other policyholders’ funds
|
350,345
|
|
|
345,721
|
|
||
|
Notes payable
|
374,445
|
|
|
374,433
|
|
||
|
Income taxes
|
122,925
|
|
|
114,611
|
|
||
|
Other liabilities
|
366,669
|
|
|
358,577
|
|
||
|
Payable under securities lending
|
133,325
|
|
|
139,927
|
|
||
|
Separate account liabilities
|
2,614,669
|
|
|
2,618,115
|
|
||
|
Commitments and contingent liabilities (
see Commitments and Contingent Liabilities note
)
|
|
|
|
||||
|
Total liabilities
|
9,125,463
|
|
|
9,062,461
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Common stock ($.01 par value; authorized 500,000 in 2013 and 2012; and issued 56,682 shares in 2013 and 56,374 shares in 2012)
|
567
|
|
|
564
|
|
||
|
Paid-in capital
|
609,100
|
|
|
602,269
|
|
||
|
Retained earnings
|
535,609
|
|
|
503,173
|
|
||
|
Accumulated other comprehensive income (loss), net of income tax:
|
|
|
|
||||
|
Unrealized foreign currency translation gains (losses)
|
51,358
|
|
|
55,487
|
|
||
|
Net unrealized investment gains (losses):
|
|
|
|
||||
|
Net unrealized investment gains not other-than-temporarily impaired
|
112,264
|
|
|
114,958
|
|
||
|
Net unrealized investment losses other-than-temporarily impaired
|
(1,045
|
)
|
|
(1,035
|
)
|
||
|
Total stockholders’ equity
|
1,307,853
|
|
|
1,275,416
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
10,433,316
|
|
|
$
|
10,337,877
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands, except per-share amounts)
|
||||||
|
Revenues:
|
|
|
|
||||
|
Direct premiums
|
$
|
570,899
|
|
|
$
|
561,037
|
|
|
Ceded premiums
|
(410,604
|
)
|
|
(418,163
|
)
|
||
|
Net premiums
|
160,295
|
|
|
142,874
|
|
||
|
Commissions and fees
|
111,988
|
|
|
103,905
|
|
||
|
Net investment income
|
23,216
|
|
|
26,097
|
|
||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
2,286
|
|
|
2,131
|
|
||
|
Other, net
|
10,660
|
|
|
11,594
|
|
||
|
Total revenues
|
308,445
|
|
|
286,601
|
|
||
|
Benefits and expenses:
|
|
|
|
||||
|
Benefits and claims
|
74,246
|
|
|
67,933
|
|
||
|
Amortization of deferred policy acquisition costs
|
31,252
|
|
|
26,531
|
|
||
|
Sales commissions
|
55,048
|
|
|
49,717
|
|
||
|
Insurance expenses
|
27,052
|
|
|
22,444
|
|
||
|
Insurance commissions
|
6,066
|
|
|
8,496
|
|
||
|
Interest expense
|
8,795
|
|
|
6,910
|
|
||
|
Other operating expenses
|
45,754
|
|
|
41,105
|
|
||
|
Total benefits and expenses
|
248,213
|
|
|
223,136
|
|
||
|
Income before income taxes
|
60,232
|
|
|
63,465
|
|
||
|
Income taxes
|
21,387
|
|
|
21,709
|
|
||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
|
|
|
|
||||
|
Earnings per share:
|
|
|
|
||||
|
Basic
|
$
|
0.67
|
|
|
$
|
0.62
|
|
|
Diluted
|
$
|
0.65
|
|
|
$
|
0.61
|
|
|
|
|
|
|
||||
|
Weighted-average shares used in computing earnings per share:
|
|
|
|
||||
|
Basic
|
56,598
|
|
|
65,133
|
|
||
|
Diluted
|
58,407
|
|
|
66,275
|
|
||
|
|
|
|
|
||||
|
Supplemental disclosures:
|
|
|
|
||||
|
Total impairment losses
|
$
|
(86
|
)
|
|
$
|
(701
|
)
|
|
Impairment losses recognized in other comprehensive income before income taxes
|
15
|
|
|
487
|
|
||
|
Net impairment losses recognized in earnings
|
(71
|
)
|
|
(214
|
)
|
||
|
Other net realized investment gains (losses)
|
2,357
|
|
|
2,345
|
|
||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
$
|
2,286
|
|
|
$
|
2,131
|
|
|
Dividends declared per share
|
$
|
0.11
|
|
|
$
|
0.03
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
Other comprehensive income (loss) before income taxes:
|
|
|
|
||||
|
Unrealized investment gains (losses):
|
|
|
|
||||
|
Change in unrealized holding gains (losses) on investment securities
|
(2,500
|
)
|
|
17,514
|
|
||
|
Reclassification adjustment for realized investment (gains) losses included in net income
|
(1,659
|
)
|
|
(1,821
|
)
|
||
|
Foreign currency translation adjustments:
|
|
|
|
||||
|
Change in unrealized foreign currency translation gains (losses)
|
(4,188
|
)
|
|
3,308
|
|
||
|
Total other comprehensive income (loss) before income taxes
|
(8,347
|
)
|
|
19,001
|
|
||
|
Income tax expense (benefit) related to items of other comprehensive income (loss)
|
(1,514
|
)
|
|
5,464
|
|
||
|
Other comprehensive income (loss), net of income taxes
|
(6,833
|
)
|
|
13,537
|
|
||
|
Total comprehensive income
|
$
|
32,012
|
|
|
$
|
55,293
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Common stock:
|
|
|
|
||||
|
Balance, beginning of period
|
$
|
564
|
|
|
$
|
649
|
|
|
Repurchases of common stock
|
(1
|
)
|
|
(1
|
)
|
||
|
Net issuance of common stock
|
4
|
|
|
5
|
|
||
|
Balance, end of period
|
567
|
|
|
653
|
|
||
|
Paid-in capital:
|
|
|
|
||||
|
Balance, beginning of period
|
602,269
|
|
|
835,232
|
|
||
|
Share-based compensation
|
9,912
|
|
|
7,058
|
|
||
|
Net issuance of common stock
|
(4
|
)
|
|
(5
|
)
|
||
|
Repurchases of common stock
|
(3,077
|
)
|
|
(1,633
|
)
|
||
|
Net capital contributed by Citigroup
|
—
|
|
|
1,961
|
|
||
|
Balance, end of period
|
609,100
|
|
|
842,613
|
|
||
|
Retained earnings:
|
|
|
|
||||
|
Balance, beginning of period
|
503,173
|
|
|
344,104
|
|
||
|
Net income
|
38,845
|
|
|
41,756
|
|
||
|
Dividends
|
(6,409
|
)
|
|
(2,013
|
)
|
||
|
Balance, end of period
|
535,609
|
|
|
383,847
|
|
||
|
Accumulated other comprehensive income (loss):
|
|
|
|
||||
|
Balance, beginning of period
|
169,410
|
|
|
146,665
|
|
||
|
Change in foreign currency translation adjustment, net of income tax expense (benefit) of $(59) in 2013 and $(29) in 2012
|
(4,129
|
)
|
|
3,337
|
|
||
|
Change in net unrealized investment gains (losses) during the period, net of income taxes:
|
|
|
|
||||
|
Change in net unrealized investment gains (losses) not-other-than temporarily impaired, net of income tax expense (benefit) of $(1,450) in 2013 and $5,664 in 2012
|
(2,694
|
)
|
|
10,516
|
|
||
|
Change in net unrealized investment losses other-than-temporarily impaired, net of income tax benefit of ($5) in 2013 and ($171) in 2012
|
(10
|
)
|
|
(316
|
)
|
||
|
Balance, end of period
|
162,577
|
|
|
160,202
|
|
||
|
Total stockholders’ equity
|
$
|
1,307,853
|
|
|
$
|
1,387,315
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
Adjustments to reconcile net income to cash provided by (used in) operating activities:
|
|
|
|
||||
|
Change in future policy benefits and other policy liabilities
|
65,701
|
|
|
70,976
|
|
||
|
Deferral of policy acquisition costs
|
(62,874
|
)
|
|
(65,346
|
)
|
||
|
Amortization of deferred policy acquisition costs
|
31,252
|
|
|
26,531
|
|
||
|
Change in income taxes
|
5,725
|
|
|
1,723
|
|
||
|
Realized investment (gains) losses, including other-than-temporary impairments
|
(2,286
|
)
|
|
(2,131
|
)
|
||
|
Accretion and amortization of investments
|
(526
|
)
|
|
(278
|
)
|
||
|
Depreciation and amortization
|
2,424
|
|
|
2,491
|
|
||
|
Change in due from reinsurers
|
(345
|
)
|
|
(39,844
|
)
|
||
|
Change in premiums and other receivables
|
(10,245
|
)
|
|
4,785
|
|
||
|
Trading securities sold, matured, or called (acquired), net
|
(1,654
|
)
|
|
3,807
|
|
||
|
Share-based compensation
|
5,196
|
|
|
4,448
|
|
||
|
Change in other operating assets and liabilities, net
|
(6,841
|
)
|
|
(53,688
|
)
|
||
|
Net cash provided by (used in) operating activities
|
64,372
|
|
|
(4,770
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Available-for-sale investments sold, matured or called:
|
|
|
|
||||
|
Fixed-maturity securities - sold
|
15,878
|
|
|
67,354
|
|
||
|
Fixed-maturity securities - matured or called
|
62,567
|
|
|
75,433
|
|
||
|
Equity securities
|
148
|
|
|
—
|
|
||
|
Available-for-sale investments acquired:
|
|
|
|
||||
|
Fixed-maturity securities
|
(34,958
|
)
|
|
(107,467
|
)
|
||
|
Equity securities
|
(46
|
)
|
|
(3,040
|
)
|
||
|
Purchases of property and equipment and other investing activities, net
|
(8,688
|
)
|
|
(322
|
)
|
||
|
Cash collateral received (returned) on loaned securities, net
|
(6,602
|
)
|
|
(6,851
|
)
|
||
|
Sales (purchases) of short-term investments using securities lending collateral, net
|
6,602
|
|
|
6,851
|
|
||
|
Net cash provided by (used in) investing activities
|
34,901
|
|
|
31,958
|
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Dividends paid
|
(6,409
|
)
|
|
(2,013
|
)
|
||
|
Common stock repurchased
|
(3,078
|
)
|
|
(1,634
|
)
|
||
|
Excess tax benefits on share-based compensation
|
925
|
|
|
396
|
|
||
|
Payments of deferred financing costs
|
—
|
|
|
(4,683
|
)
|
||
|
Net cash provided by (used in) financing activities
|
(8,562
|
)
|
|
(7,934
|
)
|
||
|
Effect of foreign exchange rate changes on cash
|
(415
|
)
|
|
204
|
|
||
|
Change in cash and cash equivalents
|
90,296
|
|
|
19,458
|
|
||
|
Cash and cash equivalents, beginning of period
|
112,216
|
|
|
136,078
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
202,512
|
|
|
$
|
155,536
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(In thousands)
|
||||||
|
Assets:
|
|
|
|
||||
|
Term life insurance segment
|
$
|
6,594,616
|
|
|
$
|
6,491,650
|
|
|
Investment and savings products segment
|
2,809,071
|
|
|
2,810,137
|
|
||
|
Corporate and other distributed products segment
|
1,029,629
|
|
|
1,036,090
|
|
||
|
Total assets
|
$
|
10,433,316
|
|
|
$
|
10,337,877
|
|
|
|
|
|
|
||||
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Revenues:
|
|
|
|
||||
|
Term life insurance segment
|
$
|
168,397
|
|
|
$
|
151,804
|
|
|
Investment and savings products segment
|
108,722
|
|
|
100,134
|
|
||
|
Corporate and other distributed products segment
|
31,326
|
|
|
34,663
|
|
||
|
Total revenues
|
$
|
308,445
|
|
|
$
|
286,601
|
|
|
Income (loss) before income taxes:
|
|
|
|
||||
|
Term life insurance segment
|
$
|
45,779
|
|
|
$
|
44,283
|
|
|
Investment and savings products segment
|
26,371
|
|
|
28,870
|
|
||
|
Corporate and other distributed products segment
|
(11,918
|
)
|
|
(9,688
|
)
|
||
|
Total income before income taxes
|
$
|
60,232
|
|
|
$
|
63,465
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(In thousands)
|
||||||
|
Long-lived assets by country:
|
|
|
|
||||
|
United States
|
$
|
83,059
|
|
|
$
|
82,724
|
|
|
Canada
|
556
|
|
|
450
|
|
||
|
Total long-lived assets
|
$
|
83,615
|
|
|
$
|
83,174
|
|
|
|
|
|
|
||||
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Revenues by country:
|
|
|
|
||||
|
United States
|
$
|
249,368
|
|
|
$
|
230,757
|
|
|
Canada
|
59,077
|
|
|
55,844
|
|
||
|
Total revenues
|
$
|
308,445
|
|
|
$
|
286,601
|
|
|
Income before income taxes by country:
|
|
|
|
||||
|
United States
|
$
|
44,131
|
|
|
$
|
47,773
|
|
|
Canada
|
16,101
|
|
|
15,692
|
|
||
|
Total income before income taxes
|
$
|
60,232
|
|
|
$
|
63,465
|
|
|
|
March 31, 2013
|
||||||||||||||
|
|
Cost or
amortized
cost
|
|
Gross
unrealized
gains
|
|
Gross
unrealized
losses
|
|
Fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Securities available for sale, carried at fair value:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
7,438
|
|
|
$
|
770
|
|
|
$
|
(11
|
)
|
|
$
|
8,197
|
|
|
Foreign government
|
108,978
|
|
|
14,644
|
|
|
(280
|
)
|
|
123,342
|
|
||||
|
States and political subdivisions
|
31,372
|
|
|
3,616
|
|
|
(11
|
)
|
|
34,977
|
|
||||
|
Corporates
(1)
|
1,244,380
|
|
|
129,639
|
|
|
(3,018
|
)
|
|
1,371,001
|
|
||||
|
Mortgage- and asset-backed securities
|
279,532
|
|
|
21,651
|
|
|
(771
|
)
|
|
300,412
|
|
||||
|
Total fixed-maturity securities
|
1,671,700
|
|
|
170,320
|
|
|
(4,091
|
)
|
|
1,837,929
|
|
||||
|
Equity securities
|
31,066
|
|
|
9,359
|
|
|
(148
|
)
|
|
40,277
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
1,702,766
|
|
|
$
|
179,679
|
|
|
$
|
(4,239
|
)
|
|
$
|
1,878,206
|
|
|
(1)
|
Includes approximately
$1.6 million
of other-than-temporary impairment losses recognized in accumulated other comprehensive income.
|
|
|
December 31, 2012
|
||||||||||||||
|
|
Cost or
amortized
cost
|
|
Gross
unrealized
gains
|
|
Gross
unrealized
losses
|
|
Fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Securities available for sale, carried at fair value:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
6,722
|
|
|
$
|
812
|
|
|
$
|
—
|
|
|
$
|
7,534
|
|
|
Foreign government
|
101,171
|
|
|
16,238
|
|
|
(17
|
)
|
|
117,392
|
|
||||
|
States and political subdivisions
|
31,176
|
|
|
3,596
|
|
|
(19
|
)
|
|
34,753
|
|
||||
|
Corporates
(1)
|
1,265,179
|
|
|
134,710
|
|
|
(2,763
|
)
|
|
1,397,126
|
|
||||
|
Mortgage- and asset-backed securities
|
307,334
|
|
|
23,999
|
|
|
(1,124
|
)
|
|
330,209
|
|
||||
|
Total fixed-maturity securities
|
1,711,582
|
|
|
179,355
|
|
|
(3,923
|
)
|
|
1,887,014
|
|
||||
|
Equity securities
|
29,955
|
|
|
7,529
|
|
|
(337
|
)
|
|
37,147
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
1,741,537
|
|
|
$
|
186,884
|
|
|
$
|
(4,260
|
)
|
|
$
|
1,924,161
|
|
|
(1)
|
Includes approximately
$1.6 million
of other-than-temporary impairment losses recognized in accumulated other comprehensive income.
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(In thousands)
|
||||||
|
Net unrealized investment gains (losses) including foreign currency translation adjustment and other-than-temporary impairments:
|
|
|
|
||||
|
Fixed-maturity and equity securities
|
$
|
175,440
|
|
|
$
|
182,624
|
|
|
Currency swaps
|
98
|
|
|
97
|
|
||
|
Foreign currency translation adjustment
|
(4,432
|
)
|
|
(7,456
|
)
|
||
|
Other-than-temporary impairments
|
1,607
|
|
|
1,592
|
|
||
|
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments
|
172,713
|
|
|
176,857
|
|
||
|
Deferred income taxes
|
(60,449
|
)
|
|
(61,899
|
)
|
||
|
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments, net of tax
|
$
|
112,264
|
|
|
$
|
114,958
|
|
|
|
March 31, 2013
|
||||||
|
|
Amortized cost
|
|
Fair value
|
||||
|
|
(In thousands)
|
||||||
|
Due in one year or less
|
$
|
184,489
|
|
|
$
|
190,619
|
|
|
Due after one year through five years
|
527,635
|
|
|
575,545
|
|
||
|
Due after five years through 10 years
|
639,913
|
|
|
724,329
|
|
||
|
Due after 10 years
|
40,131
|
|
|
47,024
|
|
||
|
|
1,392,168
|
|
|
1,537,517
|
|
||
|
Mortgage- and asset-backed securities
|
279,532
|
|
|
300,412
|
|
||
|
Total fixed-maturity securities
|
$
|
1,671,700
|
|
|
$
|
1,837,929
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Fixed-maturity securities
|
$
|
23,210
|
|
|
$
|
25,762
|
|
|
Equity securities
|
272
|
|
|
223
|
|
||
|
Policy loans and other invested assets
|
320
|
|
|
350
|
|
||
|
Cash and cash equivalents
|
88
|
|
|
135
|
|
||
|
Market return on deposit asset underlying 10% reinsurance agreement
|
563
|
|
|
1,030
|
|
||
|
Gross investment income
|
24,453
|
|
|
27,500
|
|
||
|
Investment expenses
|
(1,237
|
)
|
|
(1,403
|
)
|
||
|
Net investment income
|
$
|
23,216
|
|
|
$
|
26,097
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Net realized investment gains (losses):
|
|
|
|
||||
|
Gross gains from sales
|
$
|
1,733
|
|
|
$
|
2,036
|
|
|
Gross losses from sales
|
(3
|
)
|
|
(1
|
)
|
||
|
Other-than-temporary impairment losses
|
(71
|
)
|
|
(214
|
)
|
||
|
Gains (losses) from bifurcated options
|
627
|
|
|
310
|
|
||
|
Net realized investment gains (losses)
|
$
|
2,286
|
|
|
$
|
2,131
|
|
|
Supplemental information:
|
|
|
|
||||
|
Gross realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings
|
$
|
1,659
|
|
|
$
|
1,821
|
|
|
Tax expense (benefit) associated with realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings
|
$
|
581
|
|
|
$
|
637
|
|
|
Proceeds from sales or other redemptions
|
$
|
78,593
|
|
|
$
|
142,787
|
|
|
|
March 31, 2013
|
||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
||||||||||
|
|
(Dollars in thousands)
|
||||||||||||||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. government and agencies
|
$
|
940
|
|
|
$
|
(11
|
)
|
|
2
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
Foreign government
|
13,648
|
|
|
(255
|
)
|
|
32
|
|
|
497
|
|
|
(25
|
)
|
|
2
|
|
||||
|
States and political subdivisions
|
1,206
|
|
|
(11
|
)
|
|
3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Corporates
|
66,243
|
|
|
(1,428
|
)
|
|
162
|
|
|
5,909
|
|
|
(1,590
|
)
|
|
41
|
|
||||
|
Mortgage- and asset-backed securities
|
14,921
|
|
|
(43
|
)
|
|
24
|
|
|
6,550
|
|
|
(728
|
)
|
|
14
|
|
||||
|
Total fixed-maturity securities
|
96,958
|
|
|
(1,748
|
)
|
|
|
|
|
12,956
|
|
|
(2,343
|
)
|
|
|
|
||||
|
Equity securities
|
1,200
|
|
|
(148
|
)
|
|
7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
98,158
|
|
|
$
|
(1,896
|
)
|
|
|
|
|
$
|
12,956
|
|
|
$
|
(2,343
|
)
|
|
|
|
|
|
December 31, 2012
|
|||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|||||||||||||||||
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
|
Fair value
|
|
Unrealized
losses
|
|
Number
of
securities
|
|||||||||
|
|
(Dollars in thousands)
|
|||||||||||||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign government
|
$
|
5,146
|
|
|
$
|
(17
|
)
|
|
13
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
States and political subdivisions
|
1,498
|
|
|
(19
|
)
|
|
3
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Corporates
|
70,176
|
|
|
(1,189
|
)
|
|
134
|
|
7,055
|
|
|
(1,574
|
)
|
|
33
|
|
||||
|
Mortgage- and asset-backed securities
|
15,367
|
|
|
(22
|
)
|
|
21
|
|
6,409
|
|
|
(1,102
|
)
|
|
14
|
|
||||
|
Total fixed-maturity securities
|
92,187
|
|
|
(1,247
|
)
|
|
|
|
13,464
|
|
|
(2,676
|
)
|
|
|
|
||||
|
Equity securities
|
1,461
|
|
|
(147
|
)
|
|
20
|
|
522
|
|
|
(190
|
)
|
|
2
|
|
||||
|
Total fixed-maturity and equity securities
|
$
|
93,648
|
|
|
$
|
(1,394
|
)
|
|
|
|
$
|
13,986
|
|
|
$
|
(2,866
|
)
|
|
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||||||||||
|
|
Amortized cost
|
|
Fair value
|
|
Amortized cost
|
|
Fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fixed-maturity securities in default
|
$
|
167
|
|
|
$
|
678
|
|
|
$
|
165
|
|
|
$
|
712
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Impairments on fixed-maturity securities not in default
|
$
|
71
|
|
|
$
|
214
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Impairment losses related to securities which the Company does not intend to sell or more-likely-than-not will not be required to sell:
|
|
|
|
||||
|
Total OTTI losses recognized
|
$
|
15
|
|
|
$
|
700
|
|
|
Less portion of OTTI loss recognized in accumulated other comprehensive income (loss)
|
(15
|
)
|
|
(487
|
)
|
||
|
Net impairment losses recognized in earnings for securities which the Company does not intend to sell or more-likely-than-not will not be required to sell before recovery
|
—
|
|
|
213
|
|
||
|
OTTI losses recognized in earnings for securities which the Company intends to sell or more-likely-than-not will be required to sell before recovery
|
71
|
|
|
1
|
|
||
|
Net impairment losses recognized in earnings
|
$
|
71
|
|
|
$
|
214
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Cumulative OTTI credit losses recognized for securities still held, beginning of period
|
$
|
14,171
|
|
|
$
|
17,403
|
|
|
Additions for OTTI securities where no credit losses were recognized prior to the beginning of the period
|
71
|
|
|
—
|
|
||
|
Additions for OTTI securities where credit losses have been recognized prior to the beginning of the period
|
—
|
|
|
214
|
|
||
|
Reductions due to sales, maturities or calls of credit impaired securities
|
—
|
|
|
(2,073
|
)
|
||
|
Cumulative OTTI credit losses recognized for securities still held, end of period
|
$
|
14,242
|
|
|
$
|
15,544
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(In thousands)
|
||||||
|
Aggregate notional balance of currency swaps
|
$
|
5,878
|
|
|
$
|
5,878
|
|
|
Aggregate fair value of currency swaps
|
(1,848
|
)
|
|
(2,048
|
)
|
||
|
(4)
|
Fair Value of Financial Instruments
|
|
•
|
Level 1. Quoted prices for identical instruments in active markets. Level 1 primarily consists of financial instruments whose value is based on quoted market prices in active markets, such as exchange-traded common stocks and actively traded mutual fund investments;
|
|
•
|
Level 2. Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. Various inputs are considered in deriving the fair value of the underlying financial instrument, including interest rate, credit spread, and foreign exchange rates. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed-maturity and equity securities; government or agency securities; certain mortgage- and asset-backed securities and certain non-exchange-traded derivatives, such as currency swaps and forwards; and
|
|
•
|
Level 3. Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Level 3 consists of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and models using significant inputs not based on, nor corroborated by, readily available market information. Valuations for this category primarily consist of non-binding broker quotes. Financial instruments in this category primarily include less liquid fixed-maturity corporate securities.
|
|
|
March 31, 2013
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fair value assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
—
|
|
|
$
|
8,197
|
|
|
$
|
—
|
|
|
$
|
8,197
|
|
|
Foreign government
|
—
|
|
|
123,342
|
|
|
—
|
|
|
123,342
|
|
||||
|
States and political subdivisions
|
—
|
|
|
34,977
|
|
|
—
|
|
|
34,977
|
|
||||
|
Corporates
|
1,307
|
|
|
1,367,226
|
|
|
2,468
|
|
|
1,371,001
|
|
||||
|
Mortgage- and asset-backed securities
|
—
|
|
|
298,672
|
|
|
1,740
|
|
|
300,412
|
|
||||
|
Total fixed-maturity securities
|
1,307
|
|
|
1,832,414
|
|
|
4,208
|
|
|
1,837,929
|
|
||||
|
Equity securities
|
25,640
|
|
|
14,589
|
|
|
48
|
|
|
40,277
|
|
||||
|
Trading securities
|
—
|
|
|
9,417
|
|
|
—
|
|
|
9,417
|
|
||||
|
Separate accounts
|
—
|
|
|
2,614,669
|
|
|
—
|
|
|
2,614,669
|
|
||||
|
Total fair value assets
|
$
|
26,947
|
|
|
$
|
4,471,089
|
|
|
$
|
4,256
|
|
|
$
|
4,502,292
|
|
|
Fair value liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Currency swaps
|
$
|
—
|
|
|
$
|
1,848
|
|
|
$
|
—
|
|
|
$
|
1,848
|
|
|
Separate accounts
|
—
|
|
|
2,614,669
|
|
|
—
|
|
|
2,614,669
|
|
||||
|
Total fair value liabilities
|
$
|
—
|
|
|
$
|
2,616,517
|
|
|
$
|
—
|
|
|
$
|
2,616,517
|
|
|
|
December 31, 2012
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Fair value assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities:
|
|
|
|
|
|
|
|
||||||||
|
U.S. government and agencies
|
$
|
—
|
|
|
$
|
7,534
|
|
|
$
|
—
|
|
|
$
|
7,534
|
|
|
Foreign government
|
—
|
|
|
117,392
|
|
|
—
|
|
|
117,392
|
|
||||
|
States and political subdivisions
|
—
|
|
|
34,753
|
|
|
—
|
|
|
34,753
|
|
||||
|
Corporates
|
1,301
|
|
|
1,392,446
|
|
|
3,379
|
|
|
1,397,126
|
|
||||
|
Mortgage- and asset-backed securities
|
—
|
|
|
328,415
|
|
|
1,794
|
|
|
330,209
|
|
||||
|
Total fixed-maturity securities
|
1,301
|
|
|
1,880,540
|
|
|
5,173
|
|
|
1,887,014
|
|
||||
|
Equity securities
|
26,608
|
|
|
10,491
|
|
|
48
|
|
|
37,147
|
|
||||
|
Trading securities
|
—
|
|
|
7,762
|
|
|
—
|
|
|
7,762
|
|
||||
|
Separate accounts
|
—
|
|
|
2,618,115
|
|
|
—
|
|
|
2,618,115
|
|
||||
|
Total fair value assets
|
$
|
27,909
|
|
|
$
|
4,516,908
|
|
|
$
|
5,221
|
|
|
$
|
4,550,038
|
|
|
Fair value liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Currency swaps
|
$
|
—
|
|
|
$
|
2,048
|
|
|
$
|
—
|
|
|
$
|
2,048
|
|
|
Separate accounts
|
—
|
|
|
2,618,115
|
|
|
—
|
|
|
2,618,115
|
|
||||
|
Total fair value liabilities
|
$
|
—
|
|
|
$
|
2,620,163
|
|
|
$
|
—
|
|
|
$
|
2,620,163
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Level 3 assets, beginning of period
|
$
|
5,221
|
|
|
$
|
6,937
|
|
|
Net unrealized gains (losses) included in other comprehensive income
|
23
|
|
|
168
|
|
||
|
Net realized gains (losses) included in realized investment gains (losses), including other-than-temporary impairment losses
|
61
|
|
|
(85
|
)
|
||
|
Purchases
|
477
|
|
|
1,299
|
|
||
|
Sales
|
(10
|
)
|
|
—
|
|
||
|
Settlements
|
(525
|
)
|
|
(354
|
)
|
||
|
Transfers into Level 3
|
—
|
|
|
2,951
|
|
||
|
Transfers out of Level 3
|
(991
|
)
|
|
—
|
|
||
|
Level 3 assets, end of period
|
$
|
4,256
|
|
|
$
|
10,916
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
|
Carrying
value
|
|
Estimated
fair value
|
|
Carrying
value
|
|
Estimated
fair value
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed-maturity securities
|
$
|
1,837,929
|
|
|
$
|
1,837,929
|
|
|
$
|
1,887,014
|
|
|
$
|
1,887,014
|
|
|
Equity securities
|
40,277
|
|
|
40,277
|
|
|
37,147
|
|
|
37,147
|
|
||||
|
Trading securities
|
9,417
|
|
|
9,417
|
|
|
7,762
|
|
|
7,762
|
|
||||
|
Policy loans
|
25,009
|
|
|
25,009
|
|
|
24,613
|
|
|
24,613
|
|
||||
|
Deposit asset underlying 10% reinsurance agreement
|
100,900
|
|
|
100,900
|
|
|
91,524
|
|
|
91,524
|
|
||||
|
Separate accounts
|
2,614,669
|
|
|
2,614,669
|
|
|
2,618,115
|
|
|
2,618,115
|
|
||||
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Notes payable
|
$
|
374,445
|
|
|
$
|
419,733
|
|
|
$
|
374,433
|
|
|
$
|
418,777
|
|
|
Currency swaps
|
1,848
|
|
|
1,848
|
|
|
2,048
|
|
|
2,048
|
|
||||
|
Separate accounts
|
2,614,669
|
|
|
2,614,669
|
|
|
2,618,115
|
|
|
2,618,115
|
|
||||
|
(5)
|
Reinsurance
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(Dollars in thousands)
|
||||||
|
Direct life insurance in force
|
$
|
675,149,710
|
|
|
$
|
675,164,992
|
|
|
Amounts ceded to other companies
|
(598,422,548
|
)
|
|
(599,133,626
|
)
|
||
|
Net life insurance in force
|
$
|
76,727,162
|
|
|
$
|
76,031,366
|
|
|
Percentage of reinsured life insurance in force
|
89
|
%
|
|
89
|
%
|
||
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||
|
Reinsurance
receivable
|
|
A.M. Best
rating
|
|
Reinsurance
receivable
|
|
A.M. Best
rating
|
|||||
|
(In thousands)
|
|||||||||||
|
Prime Reinsurance Company
(1)
|
$
|
2,520,093
|
|
|
NR
|
|
$
|
2,505,157
|
|
|
NR
|
|
Financial Reassurance Company 2010, Ltd.
(1)
|
354,181
|
|
|
NR
|
|
352,073
|
|
|
NR
|
||
|
American Health and Life Insurance Company
(1)
|
173,556
|
|
|
A-
|
|
174,905
|
|
|
A-
|
||
|
Swiss Re Life & Health America Inc.
(2)
|
261,381
|
|
|
A+
|
|
266,841
|
|
|
A+
|
||
|
SCOR Global Life Reinsurance Companies
|
150,585
|
|
|
A
|
|
161,876
|
|
|
A
|
||
|
Generali USA Life Reassurance Company
|
118,612
|
|
|
A-
|
|
117,284
|
|
|
A-
|
||
|
Transamerica Reinsurance Companies
|
104,726
|
|
|
A+
|
|
108,237
|
|
|
A+
|
||
|
Munich American Reassurance Company
|
100,549
|
|
|
A+
|
|
101,349
|
|
|
A+
|
||
|
Korean Reinsurance Company
|
85,507
|
|
|
A
|
|
86,287
|
|
|
A
|
||
|
RGA Reinsurance Company
|
75,060
|
|
|
A+
|
|
72,230
|
|
|
A+
|
||
|
All other reinsurers
|
61,289
|
|
|
-
|
|
58,955
|
|
|
-
|
||
|
Due from reinsurers
|
$
|
4,005,539
|
|
|
|
|
$
|
4,005,194
|
|
|
|
|
(1)
|
Reinsurers are affiliates of Citigroup. Amounts shown are net of their share of the reinsurance receivable from other reinsurers.
|
|
(2)
|
Includes amounts ceded to Lincoln National Life Insurance and
100%
retroceded to Swiss Re Life & Health America Inc.
|
|
(6)
|
Notes Payable
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||
|
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
Senior notes payable, due July 15, 2022
|
$
|
375,000
|
|
|
4.75
|
%
|
|
$
|
375,000
|
|
|
4.75
|
%
|
|
Original issuance discount remaining on notes payable
|
(555
|
)
|
|
|
|
(567
|
)
|
|
|
||||
|
Total notes payable
|
$
|
374,445
|
|
|
|
|
$
|
374,433
|
|
|
|
||
|
(7)
|
Stockholders’ Equity
|
|
|
Three months ended March 31,
|
||||
|
|
2013
|
|
2012
|
||
|
|
(In thousands)
|
||||
|
Common stock, beginning of period
|
56,374
|
|
|
64,883
|
|
|
Shares of restricted common stock issued, net
|
289
|
|
|
422
|
|
|
Shares of common stock issued upon lapse of restricted stock units ("RSUs")
|
115
|
|
|
68
|
|
|
Common stock retired
|
(96
|
)
|
|
(69
|
)
|
|
Common stock, end of period
|
56,682
|
|
|
65,304
|
|
|
(8)
|
Earnings Per Share
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands, except per-share amounts)
|
||||||
|
Basic EPS
|
|
|
|
||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
Income attributable to unvested participating securities
|
(1,017
|
)
|
|
(1,357
|
)
|
||
|
Net income used in calculating basic EPS
|
$
|
37,828
|
|
|
$
|
40,399
|
|
|
Denominator:
|
|
|
|
||||
|
Weighted-average vested shares
|
56,598
|
|
|
65,133
|
|
||
|
Basic EPS
|
$
|
0.67
|
|
|
$
|
0.62
|
|
|
|
|
|
|
||||
|
Diluted EPS
|
|
|
|
||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
Income attributable to unvested participating securities
|
(991
|
)
|
|
(1,335
|
)
|
||
|
Net income used in calculating diluted EPS
|
$
|
37,854
|
|
|
$
|
40,421
|
|
|
Denominator:
|
|
|
|
||||
|
Weighted-average vested shares
|
56,598
|
|
|
65,133
|
|
||
|
Dilutive effect of incremental shares to be issued for warrants outstanding
|
1,809
|
|
|
1,142
|
|
||
|
Weighted-average shares used in calculating diluted EPS
(1)
|
58,407
|
|
|
66,275
|
|
||
|
Diluted EPS
|
$
|
0.65
|
|
|
$
|
0.61
|
|
|
(1)
|
Stock options granted to employees on February 20, 2013 to purchase
134,222
shares of common stock were outstanding as of
March 31, 2013
but were not included in the computation of diluted EPS, because the impact from the exercise would be anti-dilutive. There were
no
outstanding stock options as of
March 31, 2012
. See Note 9 (Share-Based Transactions) for more information regarding stock options.
|
|
(9)
|
Share-Based Transactions
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Expense for management restricted stock awards granted in 2010
|
$
|
3,025
|
|
|
$
|
3,075
|
|
|
Expense for management restricted stock awards granted in 2011
|
766
|
|
|
799
|
|
||
|
Expense for management restricted stock awards granted in 2012
|
962
|
|
|
574
|
|
||
|
Expense for management restricted stock awards granted in 2013
|
402
|
|
|
—
|
|
||
|
Total management restricted stock awards expense
|
$
|
5,155
|
|
|
$
|
4,448
|
|
|
Tax benefit associated with total management restricted stock awards expense
|
$
|
1,272
|
|
|
$
|
1,519
|
|
|
|
Three months ended March 31, 2013
|
||
|
Expected volatility
|
30.00
|
%
|
|
|
Expected per share dividend yield
|
1.35
|
%
|
|
|
Risk-free interest rate
|
1.06
|
%
|
|
|
Expected term of options using simplified method
|
6 years
|
|
|
|
Fair value per option
|
$
|
8.44
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2013
|
|
2012
|
||||
|
|
(In thousands)
|
||||||
|
Quarterly incentive awards expense recognized currently
|
$
|
—
|
|
|
$
|
—
|
|
|
Quarterly incentive awards expense deferred
|
3,805
|
|
|
1,773
|
|
||
|
Concurrent tax benefit of deferred expense
|
1,234
|
|
|
560
|
|
||
|
•
|
Business Overview
|
|
•
|
Critical Accounting Estimates
|
|
•
|
Factors Affecting Our Results
|
|
•
|
Results of Operations
|
|
•
|
Financial Condition
|
|
•
|
Liquidity and Capital Resources
|
|
|
Three months ended March 31,
|
||||
|
|
2013
|
|
2012
|
||
|
New recruits
|
46,348
|
|
|
58,551
|
|
|
New life-licensed sales representatives
|
7,165
|
|
|
7,650
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||
|
Life-licensed insurance sales representatives
|
90,917
|
|
|
92,373
|
|
|
|
Three months ended March 31,
|
||||
|
|
2013
|
|
2012
|
||
|
Average number of life-licensed sales representatives
|
91,277
|
|
|
90,027
|
|
|
Number of new policies issued
|
50,356
|
|
|
56,145
|
|
|
Average monthly rate of new policies issued per life-licensed sales representative
|
.18x
|
|
|
.21x
|
|
|
•
|
Persistency
. Persistency is a measure of how long our insurance policies stay in force. As a general matter, persistency that is lower than our pricing assumptions adversely affects our results over the long term because we lose the recurring revenue stream associated with the policies that lapse. Determining the near-term effects of changes in persistency is more complicated. When persistency is lower than our pricing assumptions, we must accelerate the amortization of DAC. The resultant increase in amortization expense is offset by a corresponding release of reserves associated with lapsed policies, which causes a reduction in benefits and claims expense. The reserves associated with any given policy will change over the term of such policy. As a general matter, reserves are lowest at the inception of a policy term and rise steadily to a peak before declining to zero at the expiration of the policy term. Accordingly, depending on when the lapse occurs in relation to the overall policy term, the reduction in benefits and claims expense may be greater or less than the increase in amortization expense and, consequently, the effects on earnings for a given period could be positive or negative. Persistency levels will impact results to the extent actual experience deviates from the persistency assumptions used to price our products.
|
|
•
|
Mortality.
Our profitability is affected to the extent actual mortality rates differ from those used in our pricing assumptions. We mitigate a significant portion of our mortality exposure through reinsurance.
|
|
•
|
Investment Yields.
We use investment yield rates based on yields available at the time a policy is issued. For policies issued in 2010 and after, we have been using an increasing interest rate assumption to reflect the historically low interest rate environment. Both DAC and the reserve liability increase with the assumed investment yield rate. Since DAC is higher than the reserve liability in the early years of a policy, a lower assumed investment yield generally will result in lower profits. In the later years, when the reserve liability is higher than DAC, a lower assumed investment yield generally will result in higher profits. These assumed investment yields, which like other pricing assumptions are locked in at issue, impact the timing but not the aggregate amount of DAC and reserve changes. Actual investment yields will impact net investment income allocated to the Term Life Insurance segment, but will not impact DAC or the reserve liability.
|
|
•
|
Ceded premiums.
Ceded premiums are the premiums we pay to reinsurers. These amounts are deducted from the direct premiums we earn to calculate our net premium revenues. Similar to direct premium revenues, ceded coinsurance premiums remain level over the initial term of the insurance policy. Ceded YRT premiums increase over the period that the policy has been in force. Accordingly, ceded YRT premiums generally constitute an increasing percentage of direct premiums over the policy term.
|
|
•
|
Benefits and claims.
Benefits and claims include incurred claim amounts and changes in future policy benefit reserves. Reinsurance reduces incurred claims in direct proportion to the percentage ceded. Coinsurance also reduces the change in future policy benefit reserves in direct proportion to the percentage ceded while YRT reinsurance does not significantly impact benefit reserves.
|
|
•
|
Amortization of DAC.
Amortization of DAC is reduced on a pro-rata basis for the coinsured business, including the business reinsured with Citigroup. There is no impact on amortization of DAC associated with our YRT contracts.
|
|
•
|
Insurance expenses.
Insurance expenses are reduced by the allowances received from coinsurance, including the business reinsured with Citigroup. There is no impact on insurance expenses associated with our YRT contracts.
|
|
•
|
sales of a higher proportion of mutual fund products of the several mutual fund families for which we act as recordkeeper will generally increase our earnings because we are entitled to recordkeeping fees on these accounts;
|
|
•
|
sales of annuity products in the United States will generate higher revenues in the period such sales occur than sales of other investment products that either generate lower upfront revenues or, in the case of managed accounts and segregated funds, no upfront revenues;
|
|
•
|
sales and administration of a higher proportion of mutual funds that enable us to earn marketing and support fees will increase our revenues and profitability;
|
|
•
|
sales of a higher proportion of retirement products of several mutual fund families will tend to result in higher revenue generation due to our ability to earn custodial fees on these accounts; and
|
|
•
|
sales of a higher proportion of managed accounts and segregated funds products will generally extend the time over which revenues can be earned because we are entitled to higher revenues based on assets under management for these accounts in lieu of upfront revenues.
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
570,899
|
|
|
$
|
561,037
|
|
|
$
|
9,862
|
|
|
2
|
%
|
|
Ceded premiums
|
(410,604
|
)
|
|
(418,163
|
)
|
|
(7,559
|
)
|
|
(2
|
)%
|
|||
|
Net premiums
|
160,295
|
|
|
142,874
|
|
|
17,421
|
|
|
12
|
%
|
|||
|
Commissions and fees
|
111,988
|
|
|
103,905
|
|
|
8,083
|
|
|
8
|
%
|
|||
|
Net investment income
|
23,216
|
|
|
26,097
|
|
|
(2,881
|
)
|
|
(11
|
)%
|
|||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
2,286
|
|
|
2,131
|
|
|
155
|
|
|
7
|
%
|
|||
|
Other, net
|
10,660
|
|
|
11,594
|
|
|
(934
|
)
|
|
(8
|
)%
|
|||
|
Total revenues
|
308,445
|
|
|
286,601
|
|
|
21,844
|
|
|
8
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
74,246
|
|
|
67,933
|
|
|
6,313
|
|
|
9
|
%
|
|||
|
Amortization of DAC
|
31,252
|
|
|
26,531
|
|
|
4,721
|
|
|
18
|
%
|
|||
|
Sales commissions
|
55,048
|
|
|
49,717
|
|
|
5,331
|
|
|
11
|
%
|
|||
|
Insurance expenses
|
27,052
|
|
|
22,444
|
|
|
4,608
|
|
|
21
|
%
|
|||
|
Insurance commissions
|
6,066
|
|
|
8,496
|
|
|
(2,430
|
)
|
|
(29
|
)%
|
|||
|
Interest expense
|
8,795
|
|
|
6,910
|
|
|
1,885
|
|
|
27
|
%
|
|||
|
Other operating expenses
|
45,754
|
|
|
41,105
|
|
|
4,649
|
|
|
11
|
%
|
|||
|
Total benefits and expenses
|
248,213
|
|
|
223,136
|
|
|
25,077
|
|
|
11
|
%
|
|||
|
Income before income taxes
|
60,232
|
|
|
63,465
|
|
|
(3,233
|
)
|
|
(5
|
)%
|
|||
|
Income taxes
|
21,387
|
|
|
21,709
|
|
|
(322
|
)
|
|
(1
|
)%
|
|||
|
Net income
|
$
|
38,845
|
|
|
$
|
41,756
|
|
|
$
|
(2,911
|
)
|
|
(7
|
)%
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
552,034
|
|
|
$
|
542,157
|
|
|
$
|
9,877
|
|
|
2
|
%
|
|
Ceded premiums
|
(407,854
|
)
|
|
(414,559
|
)
|
|
(6,705
|
)
|
|
(2
|
)%
|
|||
|
Net premiums
|
144,180
|
|
|
127,598
|
|
|
16,582
|
|
|
13
|
%
|
|||
|
Allocated net investment income
|
17,233
|
|
|
16,660
|
|
|
573
|
|
|
3
|
%
|
|||
|
Other, net
|
6,984
|
|
|
7,546
|
|
|
(562
|
)
|
|
(7
|
)%
|
|||
|
Total revenues
|
168,397
|
|
|
151,804
|
|
|
16,593
|
|
|
11
|
%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
65,547
|
|
|
57,509
|
|
|
8,038
|
|
|
14
|
%
|
|||
|
Amortization of DAC
|
27,865
|
|
|
23,933
|
|
|
3,932
|
|
|
16
|
%
|
|||
|
Insurance commissions
|
1,199
|
|
|
3,577
|
|
|
(2,378
|
)
|
|
(66
|
)%
|
|||
|
Insurance expenses
|
23,755
|
|
|
19,717
|
|
|
4,038
|
|
|
20
|
%
|
|||
|
Interest expense
|
4,252
|
|
|
2,785
|
|
|
1,467
|
|
|
53
|
%
|
|||
|
Total benefits and expenses
|
122,618
|
|
|
107,521
|
|
|
15,097
|
|
|
14
|
%
|
|||
|
Income before income taxes
|
$
|
45,779
|
|
|
$
|
44,283
|
|
|
$
|
1,496
|
|
|
3
|
%
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in millions)
|
|||||||||||||
|
Face amount in force, beginning of period
|
$
|
670,412
|
|
|
$
|
664,955
|
|
|
$
|
5,457
|
|
|
1
|
%
|
|
Issued face amount
|
15,709
|
|
|
16,983
|
|
|
(1,274
|
)
|
|
(8
|
)%
|
|||
|
Terminations
|
(14,917
|
)
|
|
(16,307
|
)
|
|
(1,390
|
)
|
|
(9
|
)%
|
|||
|
Foreign currency
|
(790
|
)
|
|
(1,208
|
)
|
|
418
|
|
|
(35
|
)%
|
|||
|
Face amount in force, end of period
|
$
|
670,414
|
|
|
$
|
664,423
|
|
|
$
|
5,991
|
|
|
1
|
%
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Commissions and fees:
|
|
|
|
|
|
|
|
|||||||
|
Sales-based revenues
|
$
|
49,433
|
|
|
$
|
44,467
|
|
|
$
|
4,966
|
|
|
11
|
%
|
|
Asset-based revenues
|
47,428
|
|
|
43,722
|
|
|
3,706
|
|
|
8
|
%
|
|||
|
Account-based revenues
|
9,454
|
|
|
9,373
|
|
|
81
|
|
|
1
|
%
|
|||
|
Other, net
|
2,407
|
|
|
2,572
|
|
|
(165
|
)
|
|
(6
|
)%
|
|||
|
Total revenues
|
108,722
|
|
|
100,134
|
|
|
8,588
|
|
|
9
|
%
|
|||
|
Expenses:
|
|
|
|
|
|
|
|
|||||||
|
Amortization of DAC
|
2,892
|
|
|
3,223
|
|
|
(331
|
)
|
|
(10
|
)%
|
|||
|
Insurance commissions
|
2,275
|
|
|
2,149
|
|
|
126
|
|
|
6
|
%
|
|||
|
Sales commissions:
|
|
|
|
|
|
|
|
|||||||
|
Sales-based
|
35,403
|
|
|
31,600
|
|
|
3,803
|
|
|
12
|
%
|
|||
|
Asset-based
|
16,637
|
|
|
14,745
|
|
|
1,892
|
|
|
13
|
%
|
|||
|
Other operating expenses
|
25,144
|
|
|
19,547
|
|
|
5,597
|
|
|
29
|
%
|
|||
|
Total expenses
|
82,351
|
|
|
71,264
|
|
|
11,087
|
|
|
16
|
%
|
|||
|
Income before income taxes
|
$
|
26,371
|
|
|
$
|
28,870
|
|
|
$
|
(2,499
|
)
|
|
(9
|
)%
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in millions and accounts in thousands)
|
|||||||||||||
|
Product sales:
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
$
|
712
|
|
|
$
|
612
|
|
|
$
|
100
|
|
|
16
|
%
|
|
Annuities and other
|
480
|
|
|
429
|
|
|
51
|
|
|
12
|
%
|
|||
|
Total sales-based revenue generating product sales
|
1,192
|
|
|
1,041
|
|
|
151
|
|
|
15
|
%
|
|||
|
Managed accounts
|
57
|
|
|
23
|
|
|
34
|
|
|
*
|
|
|||
|
Segregated funds and other
|
116
|
|
|
124
|
|
|
(8
|
)
|
|
(6
|
)%
|
|||
|
Total product sales
|
$
|
1,365
|
|
|
$
|
1,188
|
|
|
$
|
177
|
|
|
15
|
%
|
|
Average client asset values:
|
|
|
|
|
|
|
|
|||||||
|
Retail mutual funds
|
$
|
25,170
|
|
|
$
|
23,694
|
|
|
$
|
1,476
|
|
|
6
|
%
|
|
Annuities and other
|
10,310
|
|
|
8,717
|
|
|
1,593
|
|
|
18
|
%
|
|||
|
Managed accounts
|
652
|
|
|
212
|
|
|
440
|
|
|
*
|
|
|||
|
Segregated funds
|
2,624
|
|
|
2,499
|
|
|
125
|
|
|
5
|
%
|
|||
|
Total average client asset values
|
$
|
38,756
|
|
|
$
|
35,122
|
|
|
$
|
3,634
|
|
|
10
|
%
|
|
Average number of fee-generating accounts:
|
|
|
|
|
|
|
|
|||||||
|
Recordkeeping accounts
|
2,536
|
|
|
2,584
|
|
|
(48
|
)
|
|
(2
|
)%
|
|||
|
Custodial accounts
|
1,940
|
|
|
1,945
|
|
|
(5
|
)
|
|
*
|
|
|||
|
*
|
Less than 1% or not meaningful
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in millions)
|
|||||||||||||
|
Asset values, beginning of period
|
$
|
37,386
|
|
|
$
|
33,664
|
|
|
$
|
3,722
|
|
|
11
|
%
|
|
Inflows
|
1,365
|
|
|
1,188
|
|
|
177
|
|
|
15
|
%
|
|||
|
Redemptions
|
(1,305
|
)
|
|
(1,233
|
)
|
|
72
|
|
|
6
|
%
|
|||
|
Change in market value, net and other
|
2,407
|
|
|
2,660
|
|
|
(253
|
)
|
|
(10
|
)%
|
|||
|
Asset values, end of period
|
$
|
39,853
|
|
|
$
|
36,279
|
|
|
$
|
3,574
|
|
|
10
|
%
|
|
|
Three months ended March 31,
|
|
Change
|
|||||||||||
|
|
2013
|
|
2012
|
|
$
|
|
%
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|||||||
|
Direct premiums
|
$
|
18,865
|
|
|
$
|
18,880
|
|
|
$
|
(15
|
)
|
|
*
|
|
|
Ceded premiums
|
(2,750
|
)
|
|
(3,604
|
)
|
|
(854
|
)
|
|
(24
|
)%
|
|||
|
Net premiums
|
16,115
|
|
|
15,276
|
|
|
839
|
|
|
5
|
%
|
|||
|
Commissions and fees
|
5,673
|
|
|
6,343
|
|
|
(670
|
)
|
|
(11
|
)%
|
|||
|
Allocated net investment income
|
5,983
|
|
|
9,437
|
|
|
(3,454
|
)
|
|
(37
|
)%
|
|||
|
Realized investment gains (losses), including other-than-temporary impairment losses
|
2,286
|
|
|
2,131
|
|
|
155
|
|
|
7
|
%
|
|||
|
Other, net
|
1,269
|
|
|
1,476
|
|
|
(207
|
)
|
|
(14
|
)%
|
|||
|
Total revenues
|
31,326
|
|
|
34,663
|
|
|
(3,337
|
)
|
|
(10
|
)%
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|||||||
|
Benefits and claims
|
8,699
|
|
|
10,424
|
|
|
(1,725
|
)
|
|
(17
|
)%
|
|||
|
Amortization of DAC
|
495
|
|
|
(625
|
)
|
|
1,120
|
|
|
*
|
|
|||
|
Insurance commissions
|
2,592
|
|
|
2,770
|
|
|
(178
|
)
|
|
(6
|
)%
|
|||
|
Insurance expenses
|
3,297
|
|
|
2,727
|
|
|
570
|
|
|
21
|
%
|
|||
|
Sales commissions
|
3,008
|
|
|
3,372
|
|
|
(364
|
)
|
|
(11
|
)%
|
|||
|
Interest expense
|
4,543
|
|
|
4,125
|
|
|
418
|
|
|
10
|
%
|
|||
|
Other operating expenses
|
20,610
|
|
|
21,558
|
|
|
(948
|
)
|
|
(4
|
)%
|
|||
|
Total benefits and expenses
|
43,244
|
|
|
44,351
|
|
|
(1,107
|
)
|
|
(2
|
)%
|
|||
|
Loss before income taxes
|
$
|
(11,918
|
)
|
|
$
|
(9,688
|
)
|
|
$
|
2,230
|
|
|
23
|
%
|
|
*
|
Less than 1% or not meaningful
|
|
|
March 31,
2013 |
|
December 31,
2012 |
|
Average rating of our fixed-maturity portfolio
|
A
|
|
A
|
|
Average duration of our fixed-maturity portfolio
|
3.9 years
|
|
3.9 years
|
|
Average book yield of our fixed-maturity portfolio
|
5.28%
|
|
5.32%
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||
|
|
Amortized cost
|
|
%
|
|
Amortized cost
|
|
%
|
||||
|
|
(Dollars in thousands)
|
||||||||||
|
AAA
|
$
|
297,215
|
|
|
18%
|
|
$
|
317,104
|
|
|
18%
|
|
AA
|
129,270
|
|
|
8%
|
|
132,021
|
|
|
8%
|
||
|
A
|
396,816
|
|
|
23%
|
|
403,029
|
|
|
24%
|
||
|
BBB
|
768,496
|
|
|
46%
|
|
777,719
|
|
|
45%
|
||
|
Below investment grade
|
88,890
|
|
|
5%
|
|
88,422
|
|
|
5%
|
||
|
Not rated
|
430
|
|
|
*
|
|
1,049
|
|
|
*
|
||
|
Total
|
$
|
1,681,117
|
|
|
100%
|
|
$
|
1,719,344
|
|
|
100%
|
|
*
|
Less than 1%
|
|
|
March 31, 2013
|
||||||||||||
|
Issuer
|
Cost or amortized
cost
|
|
Fair
value
|
|
Unrealized
gain
|
|
Credit
rating
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
Government of Canada
|
$
|
30,617
|
|
|
$
|
32,771
|
|
|
$
|
2,154
|
|
|
AAA
|
|
General Electric Co
|
22,882
|
|
|
26,880
|
|
|
3,998
|
|
|
A
|
|||
|
International Business Machines Corp
|
12,582
|
|
|
13,608
|
|
|
1,026
|
|
|
AA-
|
|||
|
Bank of America Corp
|
11,131
|
|
|
12,063
|
|
|
932
|
|
|
BBB
|
|||
|
Province of Ontario Canada
|
9,661
|
|
|
11,732
|
|
|
2,071
|
|
|
AA-
|
|||
|
Iberdrola SA
|
9,451
|
|
|
10,514
|
|
|
1,063
|
|
|
BBB+
|
|||
|
National Rural Utilities Cooperative
|
7,189
|
|
|
10,442
|
|
|
3,253
|
|
|
A+
|
|||
|
Prologis Inc
|
9,415
|
|
|
10,364
|
|
|
949
|
|
|
BBB-
|
|||
|
Verizon Communications Inc
|
8,537
|
|
|
9,339
|
|
|
802
|
|
|
A-
|
|||
|
Province of Quebec Canada
|
7,270
|
|
|
8,808
|
|
|
1,538
|
|
|
A+
|
|||
|
Total – ten largest holdings
|
$
|
128,735
|
|
|
$
|
146,521
|
|
|
$
|
17,786
|
|
|
|
|
Total – fixed-maturity and equity securities
|
$
|
1,712,160
|
|
|
$
|
1,887,623
|
|
|
|
|
|
||
|
Percent of total fixed-maturity and equity securities
|
8
|
%
|
|
8
|
%
|
|
|
|
|
||||
|
|
Three months ended March 31,
|
|
Change
|
||||||||
|
|
2013
|
|
2012
|
|
$
|
||||||
|
|
(In thousands)
|
||||||||||
|
Net cash provided by (used in) operating activities
|
$
|
64,372
|
|
|
$
|
(4,770
|
)
|
|
$
|
69,142
|
|
|
Net cash provided by (used in) investing activities
|
34,901
|
|
|
31,958
|
|
|
2,943
|
|
|||
|
Net cash provided by (used in) financing activities
|
(8,562
|
)
|
|
(7,934
|
)
|
|
628
|
|
|||
|
Effect of foreign exchange rate changes on cash
|
(415
|
)
|
|
204
|
|
|
(619
|
)
|
|||
|
Change in cash and cash equivalents
|
$
|
90,296
|
|
|
$
|
19,458
|
|
|
$
|
70,838
|
|
|
•
|
our failure to continue to attract and license new recruits, retain sales representatives, or license or maintain the licensing of our sales representatives;
|
|
•
|
changes to the independent contractor status of our sales representatives;
|
|
•
|
our or our sales representatives' violation of, or non-compliance with, laws and regulations;
|
|
•
|
our or our sales representatives' failure to protect the confidentiality of client information;
|
|
•
|
differences between our actual experience and our expectations regarding mortality, persistency, expenses and investment yields as reflected in the pricing for our insurance policies;
|
|
•
|
the occurrence of a catastrophic event that causes a large number of premature deaths of our insureds;
|
|
•
|
changes in federal and state legislation and regulation, including other legislation or regulation that affects our insurance, investment product businesses;
|
|
•
|
our failure to meet risk-based capital standards or other minimum capital or surplus requirements;
|
|
•
|
a downgrade or potential downgrade in our insurance subsidiaries' financial strength ratings or in the investment grade credit ratings for our senior unsecured debt;
|
|
•
|
the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio;
|
|
•
|
incorrectly valuing our investments;
|
|
•
|
inadequate or unaffordable reinsurance or the failure of our reinsurers to perform their obligations;
|
|
•
|
the failure of, or legal challenges to, the support tools we provide to our sales force;
|
|
•
|
heightened standards of conduct or more stringent licensing requirements for our sales representatives;
|
|
•
|
inadequate policies and procedures regarding suitability review of client transactions;
|
|
•
|
the inability of our subsidiaries to pay dividends or make distributions;
|
|
•
|
our ability to generate and maintain a sufficient amount of working capital;
|
|
•
|
our non-compliance with the covenants of our senior unsecured debt;
|
|
•
|
legal and regulatory investigations and actions concerning us or our sales representatives;
|
|
•
|
the loss of key personnel;
|
|
•
|
the failure of our information technology systems, breach of our information security or failure of our business continuity plan; and
|
|
•
|
fluctuations in Canadian currency exchange rates.
|
|
Period
|
Total number of shares purchased
|
|
Average price paid per share
|
|
Total number of shares purchased as part of publicly announced plans or programs
|
|
Approximate dollar value of shares that may yet be purchased under the plans or programs
|
|||||
|
January 1 - 31, 2013
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
—
|
|
|
February 1 - 28, 2013
(1)
|
94,001
|
|
|
32.08
|
|
|
—
|
|
|
—
|
|
|
|
March 1 - 31, 2013
(1)
|
1,987
|
|
|
31.47
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
95,988
|
|
|
$
|
32.07
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Consists of shares surrendered to us to pay the tax withholding obligations of employees in connection with the lapsing of restriction on restricted shares and restricted stock units.
|
|
•
|
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
•
|
have been qualified by disclosures that were made to the other party in connection with the negotiation of the application agreement, which disclosures are not necessarily reflected in the agreement;
|
|
•
|
may apply standards of materiality in a way that is different from what may be viewed as material to our investors; and
|
|
•
|
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
|
|
Exhibit
Number
|
|
Description
|
|
Reference
|
|
3.1
|
|
Restated Certificate of Incorporation of the Registrant.
|
|
Incorporated by reference to Exhibit 3.1 to Primerica’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
3.2
|
|
Amended and Restated Bylaws of the Registrant.
|
|
Incorporated by reference to Exhibit 3.2 to Primerica’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 001-34680).
|
|
4.1
|
|
Indenture, dated as of July 16, 2012, between Primerica, Inc. and Wells Fargo Bank, National Association, as trustee.
|
|
Incorporated by reference to Exhibit 4.1 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
4.2
|
|
First Supplemental Indenture, dated as of July 16, 2012, between Primerica, Inc. and Wells Fargo Bank, National Association, as trustee.
|
|
Incorporated by reference to Exhibit 4.2 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
4.3
|
|
Form of 4.750% Senior Notes due 2022.
|
|
Incorporated by reference to Exhibit 4.3 (included in Exhibit 4.2 filed herewith) to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
|
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
|
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
|
|
31.3
|
|
Rule 13a-14(a)/15d-14(a) Certification, executed by Alison S. Rand, Executive Vice President and Chief Financial Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
|
|
32.1
|
|
Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350), executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer, John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer, and Alison S. Rand, Executive Vice President and Chief Financial Officer.
|
|
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.INS*
|
|
XBRL Instance Document
(1)
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
Furnished to the Securities and Exchange Commission as part of this Quarterly Report.
|
|
|
|
|
|
Primerica, Inc.
|
|
|
|
|
May 8, 2013
|
/s/ Alison S. Rand
|
|
|
Alison S. Rand
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|